Cargando…

Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1

BACKGROUND: Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregor, Anne, Albrecht, Beate, Bader, Ingrid, Bijlsma, Emilia K, Ekici, Arif B, Engels, Hartmut, Hackmann, Karl, Horn, Denise, Hoyer, Juliane, Klapecki, Jakub, Kohlhase, Jürgen, Maystadt, Isabelle, Nagl, Sandra, Prott, Eva, Tinschert, Sigrid, Ullmann, Reinhard, Wohlleber, Eva, Woods, Geoffrey, Reis, André, Rauch, Anita, Zweier, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162517/
https://www.ncbi.nlm.nih.gov/pubmed/21827697
http://dx.doi.org/10.1186/1471-2350-12-106
_version_ 1782210819699769344
author Gregor, Anne
Albrecht, Beate
Bader, Ingrid
Bijlsma, Emilia K
Ekici, Arif B
Engels, Hartmut
Hackmann, Karl
Horn, Denise
Hoyer, Juliane
Klapecki, Jakub
Kohlhase, Jürgen
Maystadt, Isabelle
Nagl, Sandra
Prott, Eva
Tinschert, Sigrid
Ullmann, Reinhard
Wohlleber, Eva
Woods, Geoffrey
Reis, André
Rauch, Anita
Zweier, Christiane
author_facet Gregor, Anne
Albrecht, Beate
Bader, Ingrid
Bijlsma, Emilia K
Ekici, Arif B
Engels, Hartmut
Hackmann, Karl
Horn, Denise
Hoyer, Juliane
Klapecki, Jakub
Kohlhase, Jürgen
Maystadt, Isabelle
Nagl, Sandra
Prott, Eva
Tinschert, Sigrid
Ullmann, Reinhard
Wohlleber, Eva
Woods, Geoffrey
Reis, André
Rauch, Anita
Zweier, Christiane
author_sort Gregor, Anne
collection PubMed
description BACKGROUND: Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous defects in either gene were reported as causative for severe intellectual disability. METHODS: 99 patients with severe intellectual disability and resemblance to Pitt-Hopkins syndrome and/or suspected recessive inheritance were screened for mutations in CNTNAP2 and NRXN1. Molecular karyotyping was performed in 45 patients. In 8 further patients with variable intellectual disability and heterozygous deletions in either CNTNAP2 or NRXN1, the remaining allele was sequenced. RESULTS: By molecular karyotyping and mutational screening of CNTNAP2 and NRXN1 in a group of severely intellectually disabled patients we identified a heterozygous deletion in NRXN1 in one patient and heterozygous splice-site, frameshift and stop mutations in CNTNAP2 in four patients, respectively. Neither in these patients nor in eight further patients with heterozygous deletions within NRXN1 or CNTNAP2 we could identify a defect on the second allele. One deletion in NRXN1 and one deletion in CNTNAP2 occurred de novo, in another family the deletion was also identified in the mother who had learning difficulties, and in all other tested families one parent was shown to be healthy carrier of the respective deletion or mutation. CONCLUSIONS: We report on patients with heterozygous defects in CNTNAP2 or NRXN1 associated with severe intellectual disability, which has only been reported for recessive defects before. These results expand the spectrum of phenotypic severity in patients with heterozygous defects in either gene. The large variability between severely affected patients and mildly affected or asymptomatic carrier parents might suggest the presence of a second hit, not necessarily located in the same gene.
format Online
Article
Text
id pubmed-3162517
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31625172011-08-27 Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1 Gregor, Anne Albrecht, Beate Bader, Ingrid Bijlsma, Emilia K Ekici, Arif B Engels, Hartmut Hackmann, Karl Horn, Denise Hoyer, Juliane Klapecki, Jakub Kohlhase, Jürgen Maystadt, Isabelle Nagl, Sandra Prott, Eva Tinschert, Sigrid Ullmann, Reinhard Wohlleber, Eva Woods, Geoffrey Reis, André Rauch, Anita Zweier, Christiane BMC Med Genet Research Article BACKGROUND: Heterozygous copy-number and missense variants in CNTNAP2 and NRXN1 have repeatedly been associated with a wide spectrum of neuropsychiatric disorders such as developmental language and autism spectrum disorders, epilepsy and schizophrenia. Recently, homozygous or compound heterozygous defects in either gene were reported as causative for severe intellectual disability. METHODS: 99 patients with severe intellectual disability and resemblance to Pitt-Hopkins syndrome and/or suspected recessive inheritance were screened for mutations in CNTNAP2 and NRXN1. Molecular karyotyping was performed in 45 patients. In 8 further patients with variable intellectual disability and heterozygous deletions in either CNTNAP2 or NRXN1, the remaining allele was sequenced. RESULTS: By molecular karyotyping and mutational screening of CNTNAP2 and NRXN1 in a group of severely intellectually disabled patients we identified a heterozygous deletion in NRXN1 in one patient and heterozygous splice-site, frameshift and stop mutations in CNTNAP2 in four patients, respectively. Neither in these patients nor in eight further patients with heterozygous deletions within NRXN1 or CNTNAP2 we could identify a defect on the second allele. One deletion in NRXN1 and one deletion in CNTNAP2 occurred de novo, in another family the deletion was also identified in the mother who had learning difficulties, and in all other tested families one parent was shown to be healthy carrier of the respective deletion or mutation. CONCLUSIONS: We report on patients with heterozygous defects in CNTNAP2 or NRXN1 associated with severe intellectual disability, which has only been reported for recessive defects before. These results expand the spectrum of phenotypic severity in patients with heterozygous defects in either gene. The large variability between severely affected patients and mildly affected or asymptomatic carrier parents might suggest the presence of a second hit, not necessarily located in the same gene. BioMed Central 2011-08-09 /pmc/articles/PMC3162517/ /pubmed/21827697 http://dx.doi.org/10.1186/1471-2350-12-106 Text en Copyright ©2011 Gregor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gregor, Anne
Albrecht, Beate
Bader, Ingrid
Bijlsma, Emilia K
Ekici, Arif B
Engels, Hartmut
Hackmann, Karl
Horn, Denise
Hoyer, Juliane
Klapecki, Jakub
Kohlhase, Jürgen
Maystadt, Isabelle
Nagl, Sandra
Prott, Eva
Tinschert, Sigrid
Ullmann, Reinhard
Wohlleber, Eva
Woods, Geoffrey
Reis, André
Rauch, Anita
Zweier, Christiane
Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
title Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
title_full Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
title_fullStr Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
title_full_unstemmed Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
title_short Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
title_sort expanding the clinical spectrum associated with defects in cntnap2 and nrxn1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162517/
https://www.ncbi.nlm.nih.gov/pubmed/21827697
http://dx.doi.org/10.1186/1471-2350-12-106
work_keys_str_mv AT gregoranne expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT albrechtbeate expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT baderingrid expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT bijlsmaemiliak expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT ekiciarifb expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT engelshartmut expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT hackmannkarl expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT horndenise expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT hoyerjuliane expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT klapeckijakub expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT kohlhasejurgen expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT maystadtisabelle expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT naglsandra expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT protteva expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT tinschertsigrid expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT ullmannreinhard expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT wohllebereva expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT woodsgeoffrey expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT reisandre expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT rauchanita expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1
AT zweierchristiane expandingtheclinicalspectrumassociatedwithdefectsincntnap2andnrxn1